Latest ischemic stroke Stories
MOUNTAIN VIEW, Calif., June 2 /PRNewswire/ -- Concentric Medical, Inc., the global leader in devices for clot removal in ischemic stroke patients, today announced an important expanded indication for the full line of DAC(TM) Neurovascular Catheters.
MOUNTAIN VIEW, Calif., May 4 /PRNewswire/ -- Concentric Medical, Inc., the global leader in devices for clot removal in ischemic stroke patients, today announced that the Merci RetrieverÂ®, MerciÂ® Microcatheter, and MerciÂ® Balloon Guide Catheter have received Shonin approval in Japan.
SAN DIEGO, April 20 /PRNewswire/ -- Stemedica Cell Technologies, Inc. (Stemedica), a world leader in stem cell research and manufacturing, announced that the U.S.
Young adults with overactive thyroid face a 44 percent increased risk of stroke compared to those with normal thyroid function.
Study highlights: -- The antiplatelet drug cilostazol was better than aspirin in preventing a recurrent stroke in a Japanese trial. -- Compared to patients taking aspirin, patients taking the drug were less likely to have new ischemic stroke or develop bleeding requiring hospitalization. -- Cilostazol is used to reduce leg pain associated with peripheral vascular disease in the United States.
Post-menopausal women who reported consuming the most daily dietary fat had a 40 percent higher incidence of clot-caused strokes compared to women who ate the least amount.
MINNEAPOLIS, Feb. 12 /PRNewswire/ -- CoAxia(TM), Inc. of Maple Grove, MN, announced today the completion of enrollment in its SENTIS randomized, controlled, pivotal trial of NeuroFlo(TM) Perfusion Augmentation Therapy as an acute interventional treatment for ischemic stroke.
American Heart Association rapid access journal report DALLAS, Feb.
MOUNTAIN VIEW, Calif., Jan. 12 /PRNewswire/ -- Concentric Medical, Inc., the global leader in acute ischemic stroke intervention, today announced that the first cases have been performed using its Trevo(TM) System in Europe.
Funding of Stroke Company Exemplifies Firm's Strategy in the Field of Medical Device PARIS and MINNEAPOLIS, June 22 /PRNewswire/ -- Sofinnova Partners of Paris, France today announced having led a $21.5M financing in Minneapolis based medical device company CoAxia.
- The deadly nightshade, Atropa Belladonna, which possesses stupefying or poisonous properties.
- A sleeping-potion; a soporific.
- To mutter deliriously.